1.A Rare Kinky Hair Disease: Menkes Syndrome
Ji Hyuck HONG ; Jun Hyuk CHO ; Sung Jin PARK ; Min Seok HAM ; Soo Hong SEO
Korean Journal of Dermatology 2022;60(1):68-69
no abstract available.
2.Impacts on outcomes and management of preoperative magnetic resonance cholangiopancreatography in patients scheduled for laparoscopic cholecystectomy:for whom it should be considered?
Kyung A KANG ; Heon-Ju KWON ; Soo-Youn HAM ; Hee Jin PARK ; Jun Ho SHIN ; Sung Ryol LEE ; Mi Sung KIM
Annals of Surgical Treatment and Research 2020;99(4):221-229
Purpose:
We evaluated the impact of preoperative magnetic resonance cholangiopancreatography (MRCP) on patient outcomes, and found which patients should be considered for MRCP before cholecystectomy.
Methods:
We performed retrospective analysis of 2,072 patients that underwent cholecystectomy for benign gallbladder disease from January 2014 to June 2017. Patients were grouped as CT only group (n = 737) and MRCP group (n = 1,335), including both CT and MRCP (n = 1,292) or MRCP only (n = 43). The main outcome measure was associated with complications after cholecystectomy, and the secondary outcomes were hospital stay, readmission, and events that could impact patient management due to addition of MRCP.
Results:
There were no statistical differences in occurrence of intraoperative or postoperative complications or readmission rate between the 2 groups. Hospital stay was about 0.6 days longer in the MRCP group. However, MRCP group was more susceptible to complications due to underlying patient demographics (older age, higher frequency of diabetes, and higher level of the inflammatory markers). MRCP diagnosed common bile duct (CBD) stones in 6.5% of patients (84/1,292) without CBD stones in CT, and bile duct anomalies were identified in 41 patients (3.2%). Elevated γ-GT was the only independent factor for additional detection of CBD stones (adjusted odds ratio [OR], 2.89; P = 0.029) and subsequent biliary procedures (adjusted OR, 3.34; P = 0.018) when additional MRCP was performed.
Conclusion
MRCP is valuable for identification of bile duct variation and CBD stones. Preoperative MRCP can be considered, particularly in patients with elevated γ-GT, for proper preoperative management and avoidance of complications.
3.Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea.
Hee Kyung KIM ; Jun Soo HAM ; Seonggyu BYEON ; Kwai Han YOO ; Ki Sun JUNG ; Haa Na SONG ; Jinhyun CHO ; Ji Yun LEE ; Sung Hee LIM ; Hae Su KIM ; Ji Yeon KIM ; Jeong Eon LEE ; Seok Won KIM ; Seok Jin NAM ; Se Kyung LEE ; Soo Youn BAE ; Jin Seok AHN ; Young Hyuck IM ; Yeon Hee PARK
Cancer Research and Treatment 2016;48(4):1382-1388
PURPOSE: The purpose of this study was to assess the tumor characteristics and long-term clinical outcomes of adjuvant treatments after surgery with a curative aim for patients with breast cancer who are 65 years and older. MATERIALS AND METHODS: Patients with breast cancer who underwent curative surgery from 2000 to 2009 were analyzed (n=4,388). Tumor characteristics and survival outcome were compared by dividing the patients into two age groups (< 65 and ≥ 65 years old). The Kaplan-Meier method was used for comparison of survival rates by log-rank test, and a Cox regression model was used to examine the effect of variables. RESULTS: Among 4,388 patients with invasive breast cancer, 317 patients (7.2%) were 65 years or older and the median age of all patients was 47 years (range, 18 to 91 years). Tumor characteristics were similar between the two age groups, but the older patients were treated less often with adjuvant treatments. During a median follow-up period of 122 months, recurrence-free survival (RFS) was equivalent for patients 65 years and older compared to younger patients, but significantly worse in overall survival (OS) and breast cancer–specific survival (BCSS) (5-year OS, 94.3% vs. 90.5%; p < 0.001 and 5-year BCSS, 94.7% vs. 91.8%; p=0.031). In the multivariate model, age ≥ 65 years old was identified as an independent risk factor for OS and RFS. CONCLUSION: Elderly breast cancer appeared to have worse outcomes with very low prevalence in Korea, despite similar tumor characteristics. More active adjuvant therapies would have a role for aggressive subtypes for fit, elderly patients.
Aged*
;
Breast Neoplasms*
;
Breast*
;
Follow-Up Studies
;
Humans
;
Korea*
;
Methods
;
Population Characteristics
;
Prevalence
;
Risk Factors
;
Survival Rate
;
Treatment Outcome
4.Renal artery stenosis presenting with nephrotic-range proteinuria: a case report.
Subin HWANG ; Jun Soo HAM ; Keum Bit HWANG ; Suk Hyeon JEONG ; Sung Hae HA ; Eun Hee KOO ; Ghee Young KWON ; Young Soo DO ; Hye Ryoun JANG
Kidney Research and Clinical Practice 2016;35(2):119-122
Renal artery stenosis (RAS) is commonly presented with hypertension and chronic kidney disease. We report a rare case of RAS occurring in a 78-year-old man who presented with nephrotic-range proteinuria. Renal biopsy on the left side was performed, and results showed mesangiopathic glomerulonephritis, which was not compatible with the cause of nephrotic-range proteinuria. Proteinuria was decreased by angiotensin receptor blocker, but azotemia was aggravated. Therefore, angiotensin receptor blocker was discontinued inevitably and thorough evaluation for the possibility of RAS was performed. Computed tomography angiography revealed significant RAS on the left side and a renal artery stent was inserted. After stenting, aortic dissection developed and progressed despite tight control of blood pressure. After inserting another stent graft through the true lumen of the left renal artery, the patient's renal function and proteinuria improved markedly.
Aged
;
Angiography
;
Angioplasty
;
Angiotensins
;
Azotemia
;
Biopsy
;
Blood Pressure
;
Blood Vessel Prosthesis
;
Glomerulonephritis
;
Humans
;
Hypertension
;
Proteinuria*
;
Renal Artery Obstruction*
;
Renal Artery*
;
Renal Insufficiency, Chronic
;
Stents
5.Establishment of a mouse model of 70% lethal dose by total-body irradiation.
Seung Hyun RYU ; Jong Hyung PARK ; Eui Suk JEONG ; Soo Young CHOI ; Seung Hoon HAM ; Jin Il PARK ; Hee Yeon JEON ; Jun Young KIM ; Ran Ji YOO ; Yong Jin LEE ; Sang Keun WOO ; Yang Kyu CHOI
Laboratory Animal Research 2016;32(2):116-121
Whereas increasing concerns about radiation exposure to nuclear disasters or side effects of anticancer radiotherapy, relatively little research for radiation damages or remedy has been done. The purpose of this study was to establish level of LD70/30 (a lethal dose for 70% of mice within 30 days) by total-body γ irradiation (TBI) in a mouse model. For this purpose, at first, 8-week-old male ICR and C57BL/6N mice from A and B companies were received high dose (10, 11, 12 Gy) TBI. After irradiation, the body weight and survival rate were monitored for 30 days consecutively. In next experiment, 5-week-old male ICR and C57BL/6N mice from B company were received same dose irradiation. Results showed that survival rate and body weight change rate in inbred C57BL/6N mice were similar between A and B company. In ICR mice, however, survival rate and body weight change rate were completely different among the companies. Significant difference of survival rate both ICR and C57BL6N mice was not observed in between 5-week-old and 8-week-old groups receiving 10 or 12 Gy TBI. Our results indicate that the strain and age of mice, and even purchasing company (especially outbred), should be matched over experimental groups in TBI experiment. Based on our results, 8-week-old male ICR mice from B company subjected to 12 Gy of TBI showed LD70/30 and suitable as a mouse model for further development of new drug using the ideal total-body irradiation model.
Animals
;
Body Weight
;
Body Weight Changes
;
Disasters
;
Humans
;
Male
;
Mice*
;
Mice, Inbred ICR
;
Radiation Exposure
;
Radiotherapy
;
Survival Rate
6.Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium simiae: The First Reported Case in South Korea.
Suk Hyeon JEONG ; Su Young KIM ; Hyun LEE ; Jun Soo HAM ; Keum Bit HWANG ; Subin HWANG ; Sun Hye SHIN ; Myung Jin CHUNG ; Seung Heon LEE ; Sung Jae SHIN ; Won Jung KOH
Tuberculosis and Respiratory Diseases 2015;78(4):432-435
This is a report of the first South Korean case of a lung disease caused by Mycobacterium simiae. The patient was a previously healthy 52-year-old female. All serial isolates were identified as M. simiae by multi-locus sequencing analysis, based on hsp65, rpoB, 16S-23S rRNA internal transcribed spacer, and 16S rRNA fragments. A chest radiography revealed deterioration, and the follow-up sputum cultures were persistently positive, despite combination antibiotic treatment, including azithromycin, ethambutol, and rifampin. To the best of our knowledge, this is the first confirmed case of a lung disease caused by M. simiae in South Korea.
Azithromycin
;
Bronchiectasis
;
Ethambutol
;
Female
;
Follow-Up Studies
;
Humans
;
Korea*
;
Lung Diseases*
;
Lung*
;
Middle Aged
;
Mycobacterium*
;
Nontuberculous Mycobacteria
;
Radiography
;
Rifampin
;
Sputum
;
Thorax
7.Skeletal Muscle Metastasis and Elevated beta-HCG Level Secondary to Tongue Cancer: a Case Report and Review of Literature.
Jun Soo HAM ; Keum Bit HWANG ; Subin HWANG ; Suk Hyeon JEONG ; Ji Yun LEE ; Se Hoon LEE ; Keunchil PARK
Korean Journal of Medicine 2015;89(6):719-722
Metastases to skeletal muscle and paraneoplastic syndromes involving beta-human chorionic gonadotropin (HCG) production are an extremely rare manifestation of head and neck squamous cell carcinoma. We report a patient with a beta-HCG-secreting squamous cell carcinoma of the tongue with diffuse metastases involving skeletal muscle. A 47 year old female, who was being treated heavily with palliative chemotherapy for metastatic tongue cancer, was admitted with a palpable thigh mass and pain. A magnetic resonance image showed an intramuscular metastasis in the thigh. Ultrasound-guided biopsy of the thigh mass confirmed metastatic squamous cell carcinoma. She was scheduled for enrollment into a clinical trial; however, a positive serum beta-HCG test was noticed. There was no evidence of pregnancy or a trophoblastic or non-trophoblastic tumor secreting beta-HCG. Finally, she was revealed to have a paraneoplastic syndrome with diffuse metastases and was ultimately referred for palliative care. We review the literature of previously reported cases of an increase of beta-HCG in patients with head and neck cancer.
Biopsy
;
Carcinoma, Squamous Cell
;
Chorionic Gonadotropin
;
Chorionic Gonadotropin, beta Subunit, Human
;
Drug Therapy
;
Female
;
Head
;
Head and Neck Neoplasms
;
Humans
;
Muscle, Skeletal*
;
Neck
;
Neoplasm Metastasis*
;
Palliative Care
;
Paraneoplastic Syndromes
;
Pregnancy
;
Thigh
;
Tongue Neoplasms*
;
Tongue*
;
Trophoblasts
8.A Case of Gastric Langerhans Cell Histiocytosis with Spontaneous Regression.
Keum Bit HWANG ; Jun Soo HAM ; Subin HWANG ; Suk Hyeon JUNG ; Jun Haeng LEE
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015;15(4):270-273
A 44-year-old male was followed-up with esophagogastroduodenoscopy due to an esophageal submucosal tumor. On the lesser curvature of the gastric low body, a 0.5 cm sized round elevated lesion with hyperemia was noticed. Two pieces of biopsy were taken from this lesion for histopathologic examination. Histology showed Langerhans cell infiltration. Immunohistochemical staining was positive for CD1a antigen, which confirmed the diagnosis of Langerhans cell histiocytosis. There was no evidence of other organ involvement. The lesions spontaneously disappeared 4 months later without any treatment. We report a very rare case of gastric Langerhans cell histiocytosis.
Adult
;
Biopsy
;
Diagnosis
;
Endoscopy, Digestive System
;
Histiocytosis, Langerhans-Cell*
;
Humans
;
Hyperemia
;
Male
;
Neoplasm Regression, Spontaneous
;
Stomach
9.A Meta-Analysis Comparing Open-Label versus Placebo- Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises.
Chi Un PAE ; Ho Jun SEO ; Boung Chul LEE ; Jeong Ho SEOK ; Hong Jin JEON ; Jong Woo PAIK ; Kyung Phil KWAK ; Byung Joo HAM ; Changsu HAN ; Soo Jung LEE
Psychiatry Investigation 2014;11(4):371-379
OBJECTIVE: The present study is to provide whether open-label studies (OLS) may properly foresee the efficacy of randomized, placebo-controlled trials (RCTs) using OLSs and RCTs data for aripiprazole in the treatment of MDD, with the use of meta-analysis approach. METHODS: A search of the studies used the key terms "depression and aripiprazole" from the databases of PubMed/PsychInfo from Jan 2005 through July 2013. The data were selected and verified for publication in English-based peer-reviewed journals based on rigorous inclusion criteria. Extracted data were delivered into and run by the Comprehensive Meta Analysis program v2. RESULTS: The pooled SMDs for the primary efficacy measure was statistically significant, pointing out the significant reduction of depressive symptoms after aripiprazole augmentation (AA) to current antidepressant treatment in OLSs (pooled SMD=-2.114, z=-9.625, p<0.001); similar results were also found in RCTs (pooled SMD=-2.202, z=-6.862, p<0.001). The meta-regression analysis revealed no influence of the study design for treatment outcome. CONCLUSION: There was no difference in the treatment effects of aripiprazole as an augmentation therapy in both OLSs and RCTs, indicating that open-label design may be a potentially useful predictor for treatment outcomes of controlled-clinical trials. The proper conduction of OLSs may provide informative, useful and preliminary clinical data and factors to be involved in controlled-clinical trials, by which we may have better understanding on the role of AA (e.g., dosing issues, proper duration of treatment, specific population for AA) implicated in the treatment of MDD in clinical practice.
Depression
;
Depressive Disorder, Major*
;
Publications
;
Treatment Outcome
;
Aripiprazole
10.Comparison of the effects and complications of combined therapies using endoscopic variceal ligation with octreotide or terlipressin in the control of acute esophageal variceal bleeding.
Se Hyung KIM ; Jung Ho HAM ; Jin Woo PARK ; Suck Ho LEE ; Hong Joo KIM ; Hyun Jun KIM ; Il Kwun CHUNG ; Hong Soo KIM ; Sang Heum PARK ; Sun Joo KIM
Korean Journal of Medicine 2005;68(2):149-156
BACKGROUND: In patients with liver cirrhosis, acute esophageal variceal bleeding is a life-threatening event with high mortality and subsequent recurrent bleeding despite of endoscopic therapy. So the effect of vasoactive agents used in combination with endoscopic therapy has been studied. The aim of this study was to compare the effects and complications of octreotide or terlipressin with endoscopic variceal ligation in the management of acute esophageal variceal bleeding. METHODS: From January, 1999 to February, 2001, 73 cirrhotic patients admitted to the Soonchunhyang University Chonan Hospital because of acute esophageal variceal bleeding were included in this study. The patients were randomized to receive either octreotide (37 patients) or terlipressin (36 patients) in combination with endoscopic variceal ligation. RESULTS: Initial control of bleeding was achieved in 35 (94.6%) patients receiving octreotide and in 33 (91.7%) patients receiving terlipressin. In the octreotide group, three patients with two cases of early rebleeding and one case of late rebleeding had rebleeding events, but in the terlipressin group, two patients with only early rebleeding bled again after initial control of bleeding. Two cases of myocardial ischemia were observed in terlipressin group, but there were no serious complications in octreotide group. CONCLUSION: This study suggests that both octreotide and terlipressin in combination with endoscopic therapy, are efficious in the initial control and the prevention of subsequent rebleeding. Octreotide showed a relatively lower risk of severe adverse reactions than terlipressin.
Chungcheongnam-do
;
Esophageal and Gastric Varices*
;
Hemorrhage
;
Humans
;
Ligation*
;
Liver Cirrhosis
;
Mortality
;
Myocardial Ischemia
;
Octreotide*

Result Analysis
Print
Save
E-mail